PAR 3.92% 24.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-3615

  1. 417 Posts.
    lightbulb Created with Sketch. 83
    Read this to understand why MDPI journals are considered predatory.

    https://predatoryreports.org/news/f/mdpi-self-citation-problem?blogcategory=Predatory+Publishing

    In short, their business model relies on negligible peer review and inflated impact factors. Their revenue comes from article processing charges (APCs) paid by the authors. Check out the points made at the end of the link above.

    I'm not saying that there is anything wrong with the review analysis and conclusions presented in the article you posted, just that the predatory reputation of the publisher suggests that the reader cannot be confident that it really is reliable. That is why I suggest readers should adopt a sceptical perspective.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.010(3.92%)
Mkt cap ! $85.70M
Open High Low Value Volume
24.5¢ 25.0¢ 24.0¢ $59.66K 241.2K

Buyers (Bids)

No. Vol. Price($)
4 78837 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 36290 1
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.